HomeLEXX • NASDAQ
add
Lexaria Bioscience Corp
Previous close
$0.73
Day range
$0.70 - $0.76
Year range
$0.46 - $2.04
Market cap
18.91M USD
Avg Volume
1.11M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Nov 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.57M | -45.21% |
Net income | -1.60M | 41.01% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.56M | 41.42% |
Effective tax rate | -0.11% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Nov 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.42M | -45.50% |
Total assets | 6.05M | -38.22% |
Total liabilities | 1.53M | 282.11% |
Total equity | 4.52M | — |
Shares outstanding | 24.89M | — |
Price to book | 3.32 | — |
Return on assets | -76.94% | — |
Return on capital | -107.23% | — |
Cash Flow
Net change in cash
| (USD) | Nov 2025info | Y/Y change |
|---|---|---|
Net income | -1.60M | 41.01% |
Cash from operations | -984.10K | 63.90% |
Cash from investing | -5.10K | 86.51% |
Cash from financing | 3.47M | -20.05% |
Net change in cash | 2.48M | 57.07% |
Free cash flow | -364.91K | 79.12% |
About
Founded
2004
Website
Employees
7
